ARSACS is a rare genetic disorder that affects the nervous system and leads to progressive impairment of coordination, balance, and speech. It is inherited in an autosomal recessive pattern, with a prevalence highest in the Charlevoix Saguenay region of Quebec, Canada. Treatment options are limited, and research is ongoing to identify the genetic mechanisms underlying the disease and develop targeted therapies.
McGill University- University of Saskatchewan- To determine of metals dysregulation in ARSACS. ongoing
Home | PROSPAX PROSPAX - an integrated multimodal progression chart in spastic ataxias” is a 3 year international collaborative research project (2020-2023) funded by the European Joint Programme on Rare Diseases (EJP RD). This project unites PIs from all major European ataxia and spastic paraplegia networks: PREPARE, SPATAX, TreatHSP, Alliance for Treatment in HSP and PLS, ERN-RND and SOLVE-RD as well as top PIs from North America and three ataxia and HSP patient organizations to overcome the limitations of current spastic ataxia research. ongoing
SACS